Geron
Foster City
About Geron
Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $999.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2024)
- Ticker: nasdaq:GERN
- Website: geron.com
- Phone: 6504737718
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/geron-41711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.